|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Evaluation of ER,PgR,HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer显示文摘 | Burcombe RJ Makris A Richman PI | 2005 | Br J Cancer2005，92，1： | 1 |
| 2 | Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracy- cline chemotherapy for operable breast cancer 显示文摘 | Burcombe R J Makris A Richman PI | 2005 | Br Cancer2005，92，1： | 1 |
| 3 | Evaluation of ER,PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer显示文摘 | Makris A Richman PI | 2005 | Br J Cancer2005，92，1： | 1 |
| 4 | Recurrentabdominal pain of gastro-intestinal origin 显示文摘 | Mavromichalis I Zaramboukas T Richman PI | 1992 | Eur J Pediatr1992，151，8： | 1 |
| 5 | Reporting basal cell carcinoma a survey of the attitudes of histopathologists显示文摘 | Milroy C J Richman PI Wilson GD | 1999 | J Clin Pathol1999，52，11： | 1 |
| 6 | Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer 显示文摘 | Burcombe R J Makris A Richman PI | 2005 | Br J Cancer2005，92，1： | 1 |
| 7 | Ki-67 derived proliferating activity in coloretal adenocarcinoma with prognostic correlatinos显示文摘 | Richman PI England JT | 1988 | J pathol1988，155，2： | 1 |
| 8 | Evaluation of ER,PgR,HER-2 and Ki-67 as predictors of response to neoadjuvant anthracy-cline chemotherapy for operable breast cancer显示文摘 | Burcombe RJ Makris A Richman PI | 2005 | British Journal of Can-cer2005，92，1： | 1 |
| 9 | Evaluation of ER,PgR,HER2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer显示文摘 | Burcombe RJ Makrie A Richman PI | 2005 | Br J Cancer2005，92，1： | 1 |
| 10 | Evaluation of ER,PgR,HER2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer显示文摘 | Burcombe RJ Makris A Richman PI | 2005 | Br J Cancer2005，92，1： | 1 |
| 11 | Evaluation of ER,PR,HER-2,and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer显示文摘 | BURCOMBE RJ MAKRIS A RICHMAN PI | 2005 | Br J cancer2005，92，1： | 1 |
| 12 | Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial 显示文摘 | Bentzen SM Atasoy BM Daley FM Dische S Richman PI Saunders MI | 2005 | J Clin Oncol2005，23，24： | 1 |
| 13 | Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk:implications for sentinel lymph nodebiopsy显示文摘 | Pearl RA Pacifico MD Richman PI | | 0，，03： | 1 |
| 14 | P53 status of head and neck cancer:relation to biological characteristics and outcome of radiotherapy显示文摘 | Wilson GD Richman PI Dische S | | 0，，： | 1 |
| 15 | Evaluation of ER,PgR, HER - 2 and Ki - 67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer 显示文摘 | Burcombe RJ Makris A Richman PI | 2005 | Br J Cancer2005，92，1： | 1 |
| 16 | Reporting basal cell carcinomata survey of the attitudes of histopathologists 显示文摘 | Milroy CJ Richman PI Wilson GD | 1999 | Clin Pathol1999，52，11： | 1 |
| 17 | Evaluation of ER,PgR,HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer显示文摘 | Burcombe RJ Makris A Richman PI | 2005 | Br J Cancer2005，92，： | 1 |
| 18 | Evaluation of ER,PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer 显示文摘 | Burcombe RJ Makrie A Richman PI | 2005 | Br J Cancer2005，92，1： | 1 |
| 19 | Measurement of invasive potential provides an accurate prognostic marker for giant cell tumour of tendon sheath显示文摘 | Grover R Grobbelaar AO Richman PI | | 0，，： | 1 |
| 20 | Evaluation of ER, PgR, HER - 2 and Ki - 67 as predictors of response to neoadjuvant anthraeycline chemotherapy for operable breast cancer 显示文摘 | Burcombe ILl Makris A Richman PI | 2005 | Br J Cancer2005，92，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员